IL84099A0 - Oral pharmaceutical compositions having enhanced absorption - Google Patents
Oral pharmaceutical compositions having enhanced absorptionInfo
- Publication number
- IL84099A0 IL84099A0 IL84099A IL8409987A IL84099A0 IL 84099 A0 IL84099 A0 IL 84099A0 IL 84099 A IL84099 A IL 84099A IL 8409987 A IL8409987 A IL 8409987A IL 84099 A0 IL84099 A0 IL 84099A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- oral pharmaceutical
- enhanced absorption
- enhanced
- absorption
- Prior art date
Links
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91615086A | 1986-10-07 | 1986-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL84099A0 true IL84099A0 (en) | 1988-03-31 |
Family
ID=25436780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84099A IL84099A0 (en) | 1986-10-07 | 1987-10-05 | Oral pharmaceutical compositions having enhanced absorption |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0263493A3 (da) |
| JP (1) | JPS6396138A (da) |
| CN (1) | CN87106855A (da) |
| AU (1) | AU7939487A (da) |
| DK (1) | DK521487A (da) |
| FI (1) | FI874382L (da) |
| HU (1) | HU196903B (da) |
| IE (1) | IE872667L (da) |
| IL (1) | IL84099A0 (da) |
| MC (1) | MC1878A1 (da) |
| NO (1) | NO874193L (da) |
| PT (1) | PT85871B (da) |
| ZA (1) | ZA876930B (da) |
| ZW (1) | ZW18787A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0643315B2 (ja) * | 1988-01-20 | 1994-06-08 | 東京田辺製薬株式会社 | 胆汁酸組成物 |
| DD293494A5 (de) * | 1989-03-29 | 1991-09-05 | Fahlberg List Gmbh Magdeburg | Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllauro-phenonoxim (hmlo) |
| CA2033714A1 (en) * | 1990-01-25 | 1991-07-26 | Alberto Ferro | Pharmaceutical preparations |
| US5534261A (en) * | 1995-01-17 | 1996-07-09 | University Of Southern California | Retinoid-based compositions and method for preventing adhesion formation using the same |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| US8093207B2 (en) * | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
| CA2744697C (en) * | 2008-11-26 | 2016-06-21 | Satiogen Pharmaceuticals, Inc. | Use of compositions comprising bile acids, salts, and mimics thereof for the treatment of obesity or diabetes |
| WO2010062861A2 (en) | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of obesity and diabetes |
| ES2552657T3 (es) | 2010-05-26 | 2015-12-01 | Satiogen Pharmaceuticals, Inc. | Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias |
| US20130108573A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| AU2012328526B2 (en) | 2011-10-28 | 2017-05-25 | Shire Human Genetic Therapies, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| CN105617353A (zh) * | 2016-01-04 | 2016-06-01 | 李志海 | 一种黏菌素口服给药组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760059A (en) * | 1985-08-05 | 1988-07-26 | Hoffmann-La Roche Inc. | Rectal dosage form |
-
1987
- 1987-09-15 ZA ZA876930A patent/ZA876930B/xx unknown
- 1987-10-05 IL IL84099A patent/IL84099A0/xx unknown
- 1987-10-05 HU HU874460A patent/HU196903B/hu not_active IP Right Cessation
- 1987-10-05 DK DK521487A patent/DK521487A/da not_active Application Discontinuation
- 1987-10-05 ZW ZW187/87A patent/ZW18787A1/xx unknown
- 1987-10-06 EP EP87114589A patent/EP0263493A3/de not_active Ceased
- 1987-10-06 NO NO874193A patent/NO874193L/no unknown
- 1987-10-06 PT PT85871A patent/PT85871B/pt unknown
- 1987-10-06 FI FI874382A patent/FI874382L/fi not_active Application Discontinuation
- 1987-10-06 MC MC871918A patent/MC1878A1/fr unknown
- 1987-10-06 IE IE872667A patent/IE872667L/xx unknown
- 1987-10-06 AU AU79394/87A patent/AU7939487A/en not_active Abandoned
- 1987-10-06 JP JP62250816A patent/JPS6396138A/ja active Pending
- 1987-10-06 CN CN198787106855A patent/CN87106855A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK521487A (da) | 1988-04-08 |
| PT85871B (en) | 1990-01-17 |
| FI874382A0 (fi) | 1987-10-06 |
| HU196903B (en) | 1989-02-28 |
| CN87106855A (zh) | 1988-04-20 |
| EP0263493A2 (de) | 1988-04-13 |
| FI874382A7 (fi) | 1988-04-08 |
| JPS6396138A (ja) | 1988-04-27 |
| AU7939487A (en) | 1988-04-14 |
| IE872667L (en) | 1988-04-07 |
| PT85871A (en) | 1987-11-01 |
| MC1878A1 (fr) | 1989-01-24 |
| DK521487D0 (da) | 1987-10-05 |
| HUT45395A (en) | 1988-07-28 |
| ZW18787A1 (en) | 1988-05-25 |
| NO874193L (no) | 1988-04-08 |
| NO874193D0 (no) | 1987-10-06 |
| EP0263493A3 (de) | 1989-06-14 |
| ZA876930B (en) | 1988-05-25 |
| FI874382L (fi) | 1988-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2196964B (en) | Pharmaceutical compositions | |
| GB8716301D0 (en) | Pharmaceutical compositions | |
| GB8723121D0 (en) | Pharmaceutical compositions | |
| GB8717582D0 (en) | Pharmaceutical compositions | |
| GB8714625D0 (en) | Pharmaceutical compositions | |
| GB8708587D0 (en) | Pharmaceutical compositions | |
| GB8717581D0 (en) | Pharmaceutical compositions | |
| GB2191696B (en) | Pharmaceutical compositions | |
| GB8618259D0 (en) | Pharmaceutical compositions | |
| GB2190838B (en) | Pharmaceutical compositions | |
| GB8728957D0 (en) | Pharmaceutical compositions | |
| IL84099A0 (en) | Oral pharmaceutical compositions having enhanced absorption | |
| GB8723120D0 (en) | Pharmaceutical compositions | |
| GB8723118D0 (en) | Pharmaceutical compositions | |
| GB2188235B (en) | Pharmaceutical compositions | |
| GR871999B (en) | Pharmaceutical compositions | |
| GB8719387D0 (en) | Pharmaceutical compositions | |
| GB8621756D0 (en) | Pharmaceutical compositions | |
| GB8713566D0 (en) | Pharmaceutical compositions | |
| GB8605037D0 (en) | Oral pharmaceutical compositions | |
| IE861385L (en) | Oral pharmaceutical composition | |
| GB8618213D0 (en) | Pharmaceutical compositions | |
| GB8626217D0 (en) | Pharmaceutical compositions | |
| GB8623588D0 (en) | Pharmaceutical compositions | |
| GB8623587D0 (en) | Pharmaceutical compositions |